Le Yin

发表

The roles of exosomal immune checkpoint proteins in tumors

Hongling Peng, Cheng Xing, Heng Li, 2021, Military Medical Research.

HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia

Xiaojuan Xiao, Peilong Wang, Hongling Peng, 2022, Pharmaceuticals.

Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms

Guangsen Zhang, Xian Jiang, Xiang Xiao, 2021, Annals of Hematology.

Identification of diagnosis and prognosis gene markers in B-ALL with ETV6-RUNX1 fusion by Integrated Bioinformatics Analysis.

Rong-Huan Zhang, Hongling Peng, Zhihua Wang, 2022, Gene.

Immune infiltration and drug specificity analysis of different subtypes based on functional status in angioimmunoblastic T-cell lymphoma

Zhihua Wang, Cheng Xing, Heng Li, 2023, Heliyon.

HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt–autophagy pathway

Guangsen Zhang, Hongling Peng, Le Yin, 2023, Human Cell.

Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma.

Le Yin, Qingyang Zhang, Qinqiao Lai, 2023, Clinical and experimental medicine.

Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma

Zhihua Wang, Cheng Xing, Le Yin, 2023, Heliyon.

Enhancing multiple myeloma staging: a novel cell death risk model approach

Zhihua Wang, Heng Li, Le Yin, 2024, Clinical and experimental medicine.